Cologuard analyzes both DNA alterations and blood in the stool to detect the presence of colon cancer and precancers. With Cologuard, patients can provide a sample in the privacy of their own home.
Cologuard is the first FDA-approved, noninvasive, stool-based DNA (sDNA) colorectal cancer screening test. Cologuard is intended for men and women 50 years or older at average risk for colorectal cancer.
Exact Sciences Corporation logo image
Cologuard logo image.